In the ER+/HER2+ subtype, TILs and colXα1 both contribute to predict chemosensitivity (Fig. 4, Tables 1 and 2), suggesting that the combination of TILs and colXα1 IHC score is a strong predictor for ER+/HER+ breast cancers. This evidence concerns the gene ESR1 and breast cancer.